Literature DB >> 16377716

Multicenter antimicrobial susceptibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China.

Thomas K W Ling1, Jianhui Xiong, Yunsong Yu, Ching Ching Lee, Huifen Ye, Peter M Hawkey.   

Abstract

A survey of 2,099 gram-negative bacilli from community infections at seven centers in the People's Republic of China is reported. The rates of resistance of 1,615 isolates of the family Enterobacteriaceae were as follows: 40.8% for ciprofloxacin, 32.2% for gentamicin, 0% for imipenem or ertapenem, and 14.7% for cefotaxime. The rates of extended-spectrum beta-lactamase production were 16% for Escherichia coli and 17% for Klebsiella.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16377716      PMCID： PMC1346789          DOI： 10.1128/AAC.50.1.374-378.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China.

Authors:  Zizhong Xiong; Demei Zhu; Fu Wang; Yingyuan Zhang; Ryoichi Okamoto; Matsuhisa Inoue
Journal:  Diagn Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.803

4.  In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

Authors:  D M Livermore; M W Carter; S Bagel; B Wiedemann; F Baquero; E Loza; H P Endtz; N van Den Braak; C J Fernandes; L Fernandes; N Frimodt-Moller; L S Rasmussen; H Giamarellou; E Giamarellos-Bourboulis; V Jarlier; J Nguyen; C E Nord; M J Struelens; C Nonhoff; J Turnidge; J Bell; R Zbinden; S Pfister; L Mixson; D L Shungu
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.

Authors:  F J Schmitz; J Verhoef; A C Fluit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-06       Impact factor: 3.267

6.  Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

Authors:  Yoichi Hirakata; Junichi Matsuda; Yoshitsugu Miyazaki; Shimeru Kamihira; Sayoko Kawakami; Yukihisa Miyazawa; Yasuo Ono; Nobuhiko Nakazaki; Yasuyoshi Hirata; Matsuhisa Inoue; John D Turnidge; Jan M Bell; Ronald N Jones; Shigeru Kohno
Journal:  Diagn Microbiol Infect Dis       Date:  2005-08       Impact factor: 2.803

7.  In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.

Authors:  R N Jones
Journal:  J Chemother       Date:  2001-08       Impact factor: 1.714

8.  Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China.

Authors:  C J Munday; J Xiong; C Li; D Shen; P M Hawkey
Journal:  Int J Antimicrob Agents       Date:  2004-02       Impact factor: 5.283

9.  [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].

Authors:  Min-Jun Chen; Hui Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-03-10

10.  SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa.

Authors:  Jan Bell; John Turnidge
Journal:  Commun Dis Intell Q Rep       Date:  2003
  10 in total
  15 in total

Review 1.  Molecular epidemiology of clinically significant antibiotic resistance genes.

Authors:  P M Hawkey
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

2.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.

Authors:  Yanling Xu; Bing Gu; Mao Huang; Haiyan Liu; Ting Xu; Wenying Xia; Tong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

3.  Multidrug-resistant community-acquired urinary tract infections in a northern region of Morocco: epidemiology and risk factors.

Authors:  Elmostafa Benaissa; Elmehdi Belouad; Youness Mechal; Yassine Benlahlou; Mariama Chadli; Adil Maleb; Mostafa Elouennass
Journal:  Germs       Date:  2021-12-29

4.  Virulence characteristics and phylogenetic background of ciprofloxacin resistant Escherichia coli in the urine samples from Korean women with acute uncomplicated cystitis.

Authors:  Chul Sung Kim; Min Eui Kim; Yong-Hyun Cho; In Rae Cho; Gilho Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

5.  Are There Differences in Antibiotic Use Between the Recent-Immigrants from Mainland China and the Local-Born in Hong Kong?

Authors:  Yuk Tsan Wun; Tai Pong Lam; Kwok Fai Lam; Pak Leung Ho; Wai Hung Raymond Yung
Journal:  J Immigr Minor Health       Date:  2015-08

Review 6.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian Hospital.

Authors:  Siva Gowri Pathmanathan; Nor Azura Samat; Ramelah Mohamed
Journal:  Malays J Med Sci       Date:  2009-04

8.  A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers.

Authors:  Caiyun Zhao; Yuan Lv; Minji Wei; Xiangyan Li; Fang Hou; Jin Wang; Xuzhu Ma; Zisheng Kang; Wei Mao; Yan Liu; Yahong Xia; Jihong Tian
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  A mutational analysis and molecular dynamics simulation of quinolone resistance proteins QnrA1 and QnrC from Proteus mirabilis.

Authors:  Qinglan Guo; Jingwei Weng; Xiaogang Xu; Minghua Wang; Xiaoying Wang; Xinyu Ye; Wenning Wang; Minggui Wang
Journal:  BMC Struct Biol       Date:  2010-10-08

10.  Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa.

Authors:  San Tin; Kishore R Sakharkar; Chu Sing Lim; Meena K Sakharkar
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.